D-Wave Quantum vs Quantum Computing
VS
Last updated:
(16h 7m ago) •
QBTS at $17.71, QUBT at $7.78
CleaRank Financial AI •
Data from
TwelveData &
CoinGecko
Reviewed by CleaRank editorial team. Data refreshed daily. Not financial advice.
Comparative Analysis
QUBT emerges as the superior investment based on its explosive revenue growth, significantly outpacing QBTS. While both stocks exhibit concerning profitability metrics and are trading below key moving averages, QUBT's hyper-growth trajectory presents a more compelling narrative for investors seeking aggressive expansion. QBTS, despite a larger market capitalization, shows a severe contraction in revenue, making its current valuation difficult to justify. Its negative returns on equity and assets further highlight fundamental challenges. QUBT, conversely, demonstrates a remarkable ability to scale its top line, even if profitability remains elusive at this stage. The stark contrast in revenue growth is the primary driver for QUBT's advantage.
Key Differentiator
The decisive factor separating QBTS and QUBT is revenue growth. QUBT's astonishing 9364.1% revenue growth presents a compelling narrative of expansion, even with profitability challenges. In stark contrast, QBTS's -80.9% revenue decline signals fundamental business deterioration, making its investment case significantly weaker.
Joint Outlook
The outlook for QUBT is cautiously optimistic, contingent on its ability to convert its impressive revenue growth into sustainable profitability. If QUBT can demonstrate improving margins and positive returns, its current valuation could prove attractive. However, a failure to achieve profitability could lead to a significant price correction, especially given its technical weakness. QBTS faces a more challenging outlook. Its severe revenue contraction and significantly negative profitability metrics suggest a fundamental business problem. Without a clear turnaround strategy or a significant shift in market dynamics, QBTS is likely to remain under pressure, with potential for further downside. Its high reported net profit margin warrants further investigation into its sustainability.
Price Analysis Comparison
Valuation Metrics
| Metric | QBTS | QUBT |
|---|---|---|
| P/E Ratio | -16.15 | -72.27 |
| Market Cap | 6.00B | 1.80B |
| Price/Sales | 482.56 | 386.65 |
| Price/Book | 5.34 | 1.05 |
| EV/EBITDA | -39.30 | -12.00 |
| Dividend Yield | N/A | N/A |
Valuation for both QBTS and QUBT is challenging due to the absence of P/E ratios. QBTS, with a market cap of $6.00 billion, is trading at $17.705, significantly below its 52-week high of $46.75 and closer to its low of $12.75. This suggests considerable downside risk or a potential value trap. QUBT, with a market cap of $1.80 billion, is priced at $7.78, also well below its 52-week high of $25.84 but showing more resilience relative to its low of $6.18. While QUBT's price action is concerning, its substantial revenue growth offers a potential justification for its current valuation, unlike QBTS which shows revenue contraction.
Profitability & Efficiency
| Metric | QBTS | QUBT |
|---|---|---|
| Rev. Growth (Qtly) | -80.90% | 9,364.10% |
| Profit Margin | 82.59% | 9.82% |
| Return on Equity | -55.27% | -4.37% |
| Return on Assets | -11.78% | -4.25% |
| Debt/Equity | 4.17 | 0.34 |
Profitability is a concern for both entities. QUBT exhibits a negative return on equity of -4.37% and a negative return on assets of -4.25%. This indicates that the company is not efficiently generating profits from its equity or assets, despite its revenue surge. QBTS presents even more alarming profitability metrics with a return on equity of -55.27% and a return on assets of -11.78%. These significantly negative figures, coupled with its severe revenue decline, paint a picture of significant financial distress, making its high reported net profit margin highly questionable.
Earnings Reality Check
QBTS
Last 4 Qs: QBTS beat estimates 3x out of 4. Fell 2x after beats. (Sell the news?)
QUBT
Last 4 Qs: QUBT beat estimates 3x out of 4. Rose 2x after beats.
Technical Indicators
| Indicator | QBTS | QUBT |
|---|---|---|
| RSI (14) | 37.49 | 41.91 |
| 50-Day MA | $22.56 | $9.77 |
| 200-Day MA | $23.41 | $10.57 |
Both QBTS and QUBT are exhibiting bearish technical signals. QBTS is trading at $17.705, below its 50-day SMA of $22.56 and its 200-day SMA of $23.41, indicating a downtrend. Its RSI of 37.49 and MACD of -1.68 further support this negative momentum. QUBT is also trading below its key moving averages, with its price at $7.78 below the 50-day SMA of $9.77 and the 200-day SMA of $10.57. Its RSI is 41.91 and MACD is -0.56, also suggesting a bearish bias, though slightly less pronounced than QBTS. Both stocks are in clear technical resistance zones.
AI Analyst Sentiment
QBTS
Strong Sell
Technical Score: 15/100
QUBT
Strong Sell
Technical Score: 15/100
Market sentiment appears cautious for both QBTS and QUBT, reflected in their current price action and technical indicators. QBTS's significant drop from its 52-week high and negative revenue growth likely contribute to a bearish sentiment among investors. The high net profit margin, if not sustainable, could also be viewed with skepticism. QUBT's hyper-growth, while positive, is tempered by its negative profitability metrics and technical weakness. Investors may be waiting for clearer signs of sustainable profitability before committing, leading to a mixed sentiment. The substantial revenue growth, however, could attract speculative interest.
Risk Stratification
| Metric | QBTS | QUBT |
|---|---|---|
| Beta (Volatility) | 2.10 | 3.78 |
| Sharpe Ratio | 1.49 | 1.34 |
The primary risk for QBTS is its severe revenue contraction and significantly negative returns on equity and assets. The sustainability of its high net profit margin is questionable, and a continued decline in revenue could lead to further significant price depreciation. Its position near the lower end of its 52-week range ($12.75 to $46.75) suggests substantial downside potential. QUBT's main risks stem from its negative profitability metrics (ROE and ROA) and its technical weakness, trading below key moving averages. While revenue growth is exceptional, the inability to translate this into profits poses a significant threat. If growth falters or market conditions shift, its current valuation could become unsustainable, leading to a sharp correction from its 52-week range ($6.18 to $25.84).
Comparative ProTips
- Prioritize QUBT for its hyper-growth potential, but monitor its path to profitability closely.
- Exercise extreme caution with QBTS given its revenue decline and questionable profitability metrics.
- Both assets are technically weak; consider waiting for improved price action or fundamental catalysts before initiating positions.
Monte Carlo Projection (10yr)
Actionable Trade Plans
Compare entry, exit, and risk management levels for both assets
Select Your Trade Bias
Risk Tolerance
Conservative
3%
Aggressive
Portfolio Value
$
✎
Position Size: $200 - $300 per asset
QBTS
Current: $17.71
ENTRY ZONES
Conservative
$18.06
Aggressive
$17.71
RISK MANAGEMENT
STOP LOSS
$18.60
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5%
$17.16
+10%
$16.25
+15%
$15.35
QUBT
Current: $7.78
ENTRY ZONES
Conservative
$7.94
Aggressive
$7.78
RISK MANAGEMENT
STOP LOSS
$8.17
MAX LOSS
-3%
Volatility-Adjusted Stop Loss
Calculated based on volatility and technical support levels.
Profit Targets (Based on Conservative)
+5%
$7.54
+10%
$7.14
+15%
$6.75
Calculate Your Trade
⚠️
Disclaimer
This comparison involves assets with varying risk profiles. The content is for educational purposes only. Comparison includes a higher-volatility asset (QBTS). Correlations between assets with different volatility profiles can break down rapidly during market stress. Liquidity risks may prevent execution at displayed prices. Note: The AI favored QUBT based on growth trajectory. This is valid for the specified timeframe only.